Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-23-003039
Filing Date
2023-02-09
Accepted
2023-02-09 19:52:38
Documents
2
Period of Report
2023-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_167599034419598.html 3  
1 FORM 3 wf-form3_167599034419598.xml 3 3523
2 JON CONGLETON POA ex-24.htm EX-24 4818
  Complete submission text file 0001628280-23-003039.txt   9724
Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address
Congleton Jon (Reporting) CIK: 0001644975 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41614 | Film No.: 23608035

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Issuer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations